In the BioHarmony Drug Report Database

"Preview" Icon

Moxifloxacin

Avelox, Moxeza, Moxifloxacin, Vigamox (moxifloxacin) is a small molecule pharmaceutical. Moxifloxacin was first approved as Avelox on 1999-12-10. It is used to treat bacterial infections, bacterial pneumonia, bacteroides infections, bronchitis, and cystitis amongst others in the USA. Vigamox’s patent is valid until 2029-05-29 (FDA).

 

Trade Name

 

Avelox, Moxeza, Moxifloxacin, Vigamox
 

Common Name

 

moxifloxacin
 

ChEMBL ID

 

CHEMBL32
 

Indication

 

bacterial infections, bacterial pneumonia, bacteroides infections, bronchitis, cystitis, escherichia coli infections, gonorrhea, haemophilus infections, klebsiella infections, proteus infections, protozoan infections, pseudomonas infections, pyelonephritis, salmonella infections, sinusitis, staphylococcal infections, streptococcal infections, urinary tract infections
 

Drug Class

 

Antibacterials (quinolone derivatives)

Image (chem structure or protein)

Moxifloxacin structure rendering